Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 4c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.44), $0.04 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $3.54 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• BMO starts chip stocks coverage: Here are its preferred picks